PfizerBioNTech

Seeking to fight the recent Covid subvariants of Omicron, US pharma giant Pfizer on Monday sought emergency authorisation for its COVID-19 booster dose for school-age children aged 5 to 11.  In its request to the  US Food…

Pfizer-BioNTech's COVID-19 vaccine for kids under five has been approved by Health Canada, making it the second vaccine option for children in this age group."After a thorough and independent scientific review of the evidence, Health Canada…

Moderna is suing Pfizer and its German partner BioNTechfor patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the…

Moderna is suing Pfizer and its German partner BioNTech for alleged patent infringement in the development of the first COVID-19 vaccine approved in the US.The lawsuit, which seeks undetermined monetary damages, alleges they…

<!-- -->Pfizer efficacy was 80.3 percent, according to a preliminary estimate. (Representational)Washington: The Pfizer-BioNTech Covid vaccine is safe and effective for children aged six months to under five years when given in three…

Results of a new multicenter study published in the New England Journal of Medicine found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in…

The United States regulators authorised a second booster dose of Pfizer Inc and BioNTech SE's Covid-19 vaccine for people 50 and older due to concerns about waning immunity in the age group, the drugmakers said on Tuesday. The U.S. Food…

Pfizer and BioNTech announced Tuesday (Mar 15) they had formally asked the United States drug regulator for emergency approval of a second booster shot of their COVID-19 vaccine for people aged 65 and older. The companies said in a press…

In this file photo taken on December 15, 2021, the Pfizer COVID-19 vaccine awaits administration at a vaccination clinic in Los Angeles, California. — AFP/FileWASHINGTON: Pfizer and BioNTech announced Tuesday they had formally asked…

Pfizer and its German partner BioNTech SE on Tuesday (Mar 15) filed an application with US regulators seeking emergency use authorisation for a second booster shot of their COVID-19 vaccine for people aged 65 and older. The submission to…